AI-DESIGNED VACCINE ENTERS HUMAN TRIALS IN WORLD FIRST
Photo Credit: Getty Images
Researchers at the University of Cambridge have developed what they describe as a fundamentally new kind of vaccine, using artificial intelligence to design its core component entirely from scratch, marking the first time an AI-engineered antigen has been tested in human volunteers.





